Ranbaxy Laboratories Ltd. vs Novartis Ag & Anr. on 18 October, 2014
Single Judge
has noted that the patent relates to a pharmaceutical product Vildagliptin.
It treats Type 2 Diabetes Mellitus. The learned Single Judge has noted ... have three
pending patent applications before the Indian Patent Office relating to
Vildagliptin formulations, Vildagliptin and Metformin hydrochloride
formulations under the brands GALVUS and GALVUSMET